Clinical Trials on ACC
Total 0 results
Nothing found
Sponsors and Collaborators
- DnaNudge Ltd
- Osaka University Japan
- Nanfang Hospital of Southern Medical University, Guangdong of China
- National Cancer Institute Center to Reduce Cancer Health Disparities
- Occupational and Environmental Medicine, Sahlgrenska UH, Gothenburg
- People's Hospital of Baise
- Roncarolo, Maria Grazia, MD
- Steno Diabetes Center Sjaelland
- Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company
- Song Zhao
- AIRWEAVE PTE. LTD.
- Joel Town
- Imbrium Therapeutics
- Xinjiang Tumor Hospital
- Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat
- Samu of Necker, Paris, France
- Centre Hospitalier de Saint-Lô
- Robin Vanderpool
- Lin Medical Center, Haifa
- Gamze Durmazoğlu
- View Full List
Medical Conditions
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Improved Vocal Fold Status
- Idiopathic Gastric Stasis
- Low Birthweight, Extremely (999 Grams or Less)
- Fecal Elastase-1 Test
- Periodontology
- Acute Necrotizing Encephalopathy
- Nutritional Edema
- Moderate to Severe Functional Impairments
- Canthal Lines
- Pediatric Anaplastic Large Cell Lymphoma
- Myeloproliferative Disease
- Postmenopausal Diabetes
- Radial Artery Catheterization
- Suspected Neonatal Encephalopathy
- Pertussis Immunisation
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Heart Defect, Congenital
- Influenza and Other Novel Respiratory Viruses
- Ketamine Treatment
- View Full List
Drug Interventions
- Ombrabulin (AVE8062)
- Postoperative analgesia management
- 200 µg doxorubicin-containing MNA
- Pentostatin
- AZD7798
- Levobupivacaine, clonidine
- Hydroxychloroquine
- Rifaximin
- CKD-519
- ESK981
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Bendamustine
- Levcromakalim
- Nimotuzumab
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Fludarabine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Burundi
- Contract Research Organizations in Finland
- Contract Research Organizations in France
- Contract Research Organizations in Gabon
- Contract Research Organizations in Guinea
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Latvia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Singapore
- CRO list by country